Get the Daily Brief

All action, no filler. BioBriefs delivers the industry’s 10 must-know updates, every morning.

Latest Biotech News

GLP-1 Telehealth Deal Raises Pharma Conflict-of-Interest Questions

November 13, 2026

Eli Lilly’s marketed GLP-1 prescribing pathway could get more complicated after Counsel Health’s announced acquisition by smart-ring maker Oura, according to experts commenting on the deal’s...

Burden and Bias in Clinical Development Oversight – FDA Voucher Program Shelved

November 13, 2026

The US FDA has shelved a fast-track drug review initiative tied to the Commissioner’s National Priority Voucher program, Reuters reported, citing six sources and internal documents. Launched in...

Asthma and COPD Pipeline – Windward Bio IPO funds TSLP strategy

November 13, 2026

Windward Bio raised $175 million in its initial public offering, setting the stage for late-stage trials of WIN378, an ultra-long-acting therapy targeting TSLP. The company, which started trading...

Cancer Therapy Signal – Trastuzumab deruxtecan posts long PFS in second-line gastroesophageal cancer

November 13, 2026

A real-world-style case report described 23-month progression-free survival after second-line trastuzumab deruxtecan in a patient with HER2-positive metastatic gastroesophageal junction...

Sepsis Risk Stratification – New pediatric sepsis prediction tool

November 13, 2026

Researchers developed an eight-marker scoring model to predict sepsis risk early in pediatric intensive care, reporting internal validation performance with an area under the ROC curve of 0.87 in...

Regulatory/Diagnostics Innovation – Rapid carbapenemase detection directly from blood cultures

November 13, 2026

A new workflow using the NG-TEST Blood Culture PREP Kit and NG-TEST CARBA 5 enables accurate detection of five major carbapenemases directly from positive blood cultures in under 25 minutes. The...

Translational Oncology Mechanism – NK state depletion tracked as immunotherapy biomarker in lung adenocarcinoma

November 13, 2026

A multi-cohort genomic analysis reports that lung adenocarcinoma tumors show marked natural killer cell depletion and a redistribution of NK states away from cytotoxic competence. Investigators...

Cardiometabolic Outcomes Signal – Remnant Cholesterol Inflammation Index predicts 30-day events in MI

November 13, 2026

A retrospective study of 3,280 acute myocardial infarction patients found a U-shaped relationship between the Remnant Cholesterol Inflammation Index and 30-day major adverse cardiovascular and...

Hospital Care Delivery – Postponed and reduced nitrogen topdressing sustains wheat yields

November 13, 2026

A two-year field experiment reports that delaying and reducing nitrogen topdressing can maintain wheat grain yield while improving nitrogen use efficiency. Researchers evaluated practical...

Biopharma Data and Coverage – insurance denials for pediatric biologics run near 40%

November 13, 2026

A study presented at the American College of Allergy, Asthma & Immunology meeting reports that 39.3% of pediatric biologic prescriptions requiring prior authorization were denied by insurance...

GLP-1 obesity development funding and trial firepower

November 13, 2026

Pfizer struck a major financing partnership with Blackstone Life Sciences to bankroll additional late-stage development for berobenatide, a once-monthly GLP-1 obesity drug acquired via Pfizer’s...

FDA priority voucher program abruptly stalled

November 13, 2026

Reuters reports the FDA has shelved its Commissioner’s National Priority Voucher program, with no new vouchers issued for at least six months after the program’s champion left the agency. While...

Bristol Myers Squibb reorganizes R&D leadership

November 13, 2026

Bristol Myers Squibb said it is reorganizing its research and development structure, combining previously separate R&D functions under a single leader. Cristian Massacesi, currently Chief Medical...

KRAS vaccine posts Phase 2 immunogenicity signal in pancreatic cancer

November 13, 2026

An investigational off-the-shelf vaccine directed against mutated KRAS generated strong T-cell responses in nearly all evaluated pancreatic cancer patients in a randomized Phase 2 trial, according...

Gene therapy durability in Crigler–Najjar

November 13, 2026

A four-year follow-up published in the New England Journal of Medicine reports that an AAV8-mediated gene therapy for Crigler–Najjar syndrome maintains disease control and safe bilirubin levels...

Microfluidics and point-of-care diagnostics: rapid Listeria detection

November 13, 2026

Researchers reported GARC, a gelatin-assisted recombinase polymerase amplification and CRISPR/Cas12a tandem assay, designed to detect Listeria monocytogenes with high sensitivity and a visually...

Real-world antimicrobial safety signals for DPP-4 inhibitor pemphigoid

November 13, 2026

A retrospective analysis in Japan found that adverse event reports for DPP-4 inhibitor-associated pemphigoid rose following regulatory package insert updates, then declined after the immediate...

Cell therapy and radioscience: radioligand pipeline execution

November 13, 2026

Radiopharmaceutical developers highlighted program progression and pipeline strategy in BIO-Europe presentations, focusing on optimizing therapeutic ratios by increasing tumor absorbed dose while...

Precision medicine: pharmacogenomic variant frequency in All of Us

November 13, 2026

A study using the NIH All of Us Research Program found that essentially all participants carried at least one pharmacogenomic variant affecting how their body processes medications, and about a...

Immunology and transplant risk modeling: dynamic liver allocation

November 13, 2026

Researchers introduced DynaMELD, a dynamic deep learning survival model that incorporates longitudinal biomarker trajectories to improve mortality prediction for liver transplant prioritization...